EP
GOSS icon

Essential Partners’s Gossamer Bio GOSS Stock Holding History

Essential Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97K Buy
378
+142
+60% +$3.17K ﹤0.01% 1549
2026
Q1 		$6.2K Buy
236
+206
+687% +$25.9K ﹤0.01% 1481
2025
Q4 		$7.54K Buy
30
+12
+67% +$2.74K ﹤0.01% 1263
2025
Q3 		$3.88K Buy
+18
New +$3.17K ﹤0.01% 1526

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Essential Partners's GOSS Position: Q2 2026 in Review

Essential Partners increased its Gossamer Bio (GOSS) stake by 60% in Q2 2026, buying an estimated $3.17K and bringing the position to 378 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Essential Partners first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.54K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Essential Partners held 378 shares of Gossamer Bio worth $4.97K as of Q2 2026.
  • Essential Partners bought 142 Gossamer Bio shares in Q2 2026, an estimated $3.17K.
  • Gossamer Bio made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1549 holding.
  • Essential Partners first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Gossamer Bio position peaked at $7.54K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.